CLINUVEL PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.86 AUD | 0.00% |
|
+1.99% | -7.12% |
| 04-29 | Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% | MT |
| 03-14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 492M | ||||||
| 40.51B | ||||||
| 31.67B | ||||||
| 24.62B | ||||||
| 15.65B | ||||||
| 12.07B |
